ASTRA 1P Starts Delivering Content Across Europe
Most powerful satellite to operate at SES’s prime TV neighbourhood of 19.2 degrees East will deliver content to 118 million TV homes
SES announced today that ASTRA 1P, the company's most advanced satellite positioned at 19.2 degrees East, has completed comprehensive testing and is now fully operational.
Following its successful in-orbit raising and performance testing, ASTRA 1P will now start serving public and private broadcasters, sports organisations and content owners, achieving another milestone in SES’s commitment to delivering high-quality broadcast services to the widest audience possible.
ASTRA 1P is SES’s most powerful wide-beam satellite to broadcast from the 19.2 degrees East TV neighbourhood. Equipped with 80 transponders, ASTRA 1P can support hundreds of HD TV channels, ensuring the delivery of superior image quality to viewers across key European TV markets.
“With ASTRA 1P now fully operational, we are setting a new standard for satellite broadcasting in Europe,” said Milton Torres, CTO of SES. “This new offering will enhance our ability to deliver premium content with superior reliability and image quality to 118 million TV households. This includes sports and events content, where we are seeing growing demand from viewers, as well as sports leagues, teams, federations and rights holders.”
Built by Thales Alenia Space, ASTRA 1P was successfully launched by SpaceX’s Falcon 9 rocket on 20 June 2024 from Cape Canaveral, Florida.
To find out more about ASTRA 1P, visit our newsroom.
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
Read our Blogs >
Visit the Media Gallery >
About SES
SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous orbit fleet and medium earth orbit (GEO-MEO) constellation of satellites, offering a combination of global coverage and high-performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241218862701/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy19.12.2024 12:00:00 CET | Press release
– Treatment with the highly selective NaV1.8 pain signal inhibitor suzetrigine met the primary endpoint with a statistically significant and clinically meaningful 2.02 point within-group reduction from baseline in the Numeric Pain Rating Scale (NPRS) –– Placebo arm showed similar within-group reduction in NPRS – – Suzetrigine was generally well tolerated –– Advancement to Phase 3 inpainful lumbosacral radiculopathy planned, pending discussions with regulators – – Vertex to host investor call on December 19 at 8:00 a.m. ET – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy (LSR). The study met its primary endpoint with statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS). Efficacy Results The study’s primary endpoint was a within-group change from
Ukraine Conflict Impacting Nordics Cloud Adoption19.12.2024 10:00:00 CET | Press release
Supply chain disruptions and skilled labor shortages are intensifying enterprise demands for better business value in the short term, ISG Provider Lens™ report says The conflict in Ukraine has intensified supply chain disruptions, affecting IT investments across the Nordics, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2024 ISG Provider Lens™ Multi Public Cloud Services report for the Nordics finds companies in the region are grappling with rising IT costs and a shortage of skilled labor, which is directly impacting their cloud adoption strategies. As a result, many organizations are focusing their investments on projects the deliver immediate business value, while deferring less critical initiatives. This trend, ISG says, underscores the need for agile and efficient cloud solutions that can adapt to evolving market conditions. The demand for hybrid and multicloud soluti
Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA19.12.2024 09:00:00 CET | Press release
- Global Market Expansion Accelerates with Back-to-Back FDA and EC Authorizations Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: DMB-3115, Active Ingredient: Ustekinumab), has received marketing authorization from the European Commission (EC) as of December 18. This landmark approval comes just two months after the Committee for Medicinal Products for Human Use (CHMP) under the European Medicine Agency (EMA) recommended the product for approval in October. Combined with its successful U.S. Food and Drug Administration (FDA) approval in October, IMULDOSA is now fully authorized to enter the global market. IMULDOSA, a biosimilar referencing Stelara of Janssen Pharmaceuticals, is indicated for treating inflammatory diseases, including plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Stelara, with its active ingredient ustekinumab, is among the top-grossing biologics worldwide, generating $20.323 billion in cum
Thales to Enhance Vehicle Access With Reliable and Secure Contactless Solutions19.12.2024 08:00:00 CET | Press release
Car industry players can rely on Thales to provide digital and physical solutions that improve car access experiences, while ensuring data security. Thales's offer encompasses a digital car key solution, whose implementation follows the Car Connectivity Consortium1 (CCC) standard. It is now completed by a brand-new contactless card, the Thales NFC CARd Key. The solutions enable car drivers to lock/unlock and start their vehicles using their smartphone or their card. Drawing on its 15+ years of experience in the automotive industry, Thales delivers proven on-board car solutions leveraging its connectivity and cybersecurity expertise. Thales, a global leader in advanced technologies, provides car manufacturers with safe and hassle-free solutions to expand their customers’ vehicle access experiences. The offer leverages the digital car key solution and the smart NFC CARd Key, a new cutting-edge and customisable solution. Designed to complement the digital key, this innovative NFC-based ca
Kao Corporation: Regarding the Nomination of Director Candidates for Our Company19.12.2024 07:45:00 CET | Press release
Kao's Board of Directors and management team strive to increase shareholder value from a long-term perspective based on our business strategy. For the purpose of enhancing our corporate value, we are committed to engaging directly and constructively with all our stakeholders and welcome new perspectives to address challenges. Kao adheres to a robust selection process to ensure an optimal composition of the Board of Directors. As announced in the December 12 press release, this fiscal year, the selection of candidates was deliberated over a period of more than six months by the Board of Directors and the Committee for Examination of Nominees for Directors and Audit & Supervisory Board Members. The candidates for Directors and Audit & Supervisory Board Members were announced on December 2 to coincide with the announcement of the new Executive Officer structure. The announced individuals are proposed candidates and do not preclude proposals from other shareholders. Following our company's
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom